EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access

Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study

Lisa A Niemann iD, Lauren R Violette iD, Andy Cornelius-Hudson iD, Maggie Murphy iD, Carl Capili iD, Mindy Dai iD, Anjuli Wagner iD, Sarah Frey iD, Shireesha Dhanireddy iD, Shaneil E Taylor iD, Karen W Hoover iD, Joanne D Stekler iD

JMIR Research Protocols · 2026

DOI: 10.2196/84625 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift JMIR Research Protocols, 2026. Verfasst von Lisa A Niemann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, 325 Ninth Avenue, Box 359931, Seattle, WA, 98104, United States, 1 206 744 8887, 1 206 744 3693. Hauptthemen laut MEDLINE: Viral Load, HIV Infections, HIV Testing, Point-of-Care Testing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCHHSTP CDC HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With shorter window periods than serologic point-of-care (POC) tests and faster turnaround than laboratory-based nucleic acid tests (NAT), POC NATs could improve early detection of HIV. Furthermore, semiquantitative POC NAT may provide real-time monitoring for persons with HIV. There have been limited evaluations of POC NAT implementation in the United States.

Objective

This paper describes the protocols and procedures used to evaluate the acceptability and feasibility of POC NAT implementation and test performance in clinical and community settings in Seattle, Washington.

Methods

The Greater Access and Impact through POC NAT (GAIN) study was a Centers for Disease Control and Prevention–funded study that enrolled participants at a Ryan White–funded, hospital-based clinic (Madison Clinic) and a community site (Seattle’s LGBTQ+ Center [the Center]). Persons seeking HIV testing, nonoccupational postexposure prophylaxis, or pre-exposure prophylaxis (PrEP) enrolled at either site received the standard of care plus the SAMBA II HIV-1 Qualitative Whole Blood Test (SAMBA Qual) and pooled laboratory HIV NAT, and persons with HIV enrolled at the Center received standard-of-care sexually transmitted infection testing plus the SAMBA II HIV-1 Semiquantitative Whole Blood Test (SAMBA Semi-Q) and laboratory viral load testing. Persons with HIV from Madison Clinic were recruited into a randomized clinical trial (RCT) to compare the clinical standard of care with the addition of the SAMBA Semi-Q (backed up by Food and Drug Administration–approved laboratory NAT). All participants completed a demographic survey during their study visit and contributed prospective data via electronic medical records. Subsets of participants from each group were invited to complete a postvisit acceptability survey and participate in an individual interview. Patient flow was observed at Madison Clinic to assess the impact of POC testing on clinic visit timing.

Results

From January 2022 to December 2024, 733 participants completed 753 GAIN research visits. Of those, 491 visits were completed by 489 participants seeking HIV testing and/or PrEP at the Center, and 61 visits were completed by 43 participants seeking HIV testing, nonoccupational postexposure prophylaxis, and/or PrEP at Madison Clinic. Test result data will assess test performance, with analyses anticipated in 2027. Seven people with HIV were enrolled at the Center, and 194 people with HIV were enrolled in the Madison Clinic RCT. Data from patients with HIV at Madison Clinic will be used to conduct a survival analysis evaluating the impact of POC NAT on time to viral suppression and to assess test performance, with analyses anticipated in 2026. In-depth acceptability surveys were completed by 193 participants, and 41 interviews were conducted. These data will contribute to qualitative and mixed methods analyses, which are anticipated in 2026. Time-and-motion observations conducted in 2021 and 2023 included 47 patients; results are anticipated in 2026.

Conclusions

The GAIN study is an important evaluation of POC NAT implementation in the United States in community and clinical care settings for HIV diagnosis and viral load monitoring. Results will be reported in future publications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral LoadHIV InfectionsHIV TestingPoint-of-Care TestingPatient Acceptance of Health CarePoint-of-Care SystemsHumansProspective StudiesFeasibility StudiesFemaleLongitudinal StudiesMaleAdultUnited StatesWashingtonMiddle AgedRapid Diagnostic TestsHIV-1

Stichwörter der Autor:innen

HIV testingnucleic acid testspoint-of-care nucleic-acid testspoint-of-care testspoint-of-care viral load testsviral load testing

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, 325 Ninth Avenue, Box 359931, Seattle, WA, 98104, United States, 1 206 744 8887, 1 206 744 3693.
  • Harvard Pilgrim Health Care Institute, Boston, MA, United States.
  • Seattle's LGBTQ+ Center, Seattle, WA, United States.
  • Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, United States.
  • Department of Global Health, University of Washington, Seattle, WA, United States.
  • Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States.

ORCID-Profile: Lisa A Niemann, Lauren R Violette, Andy Cornelius-Hudson, Maggie Murphy, Carl Capili, Mindy Dai, Anjuli Wagner, Sarah Frey, Shireesha Dhanireddy, Shaneil E Taylor, Karen W Hoover, Joanne D Stekler

Förderung

  • NCHHSTP CDC HHS
  • NCATS NIH HHS

Zitieren

APA

Niemann, L. A., Violette, L. R., Cornelius-Hudson, A., Murphy, M., Capili, C., Dai, M., Wagner, A., Frey, S., Dhanireddy, S., Taylor, S. E., Hoover, K. W., & Stekler, J. D. (2026). Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study. JMIR Research Protocols. https://doi.org/10.2196/84625

Vancouver

Niemann LA, Violette LR, Cornelius-Hudson A, Murphy M, Capili C, Dai M, et al. Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study. JMIR Research Protocols. 2026. doi:10.2196/84625

BibTeX
@article{Niemann2026,
  author = {Niemann, Lisa A and Violette, Lauren R and Cornelius-Hudson, Andy and Murphy, Maggie and Capili, Carl and Dai, Mindy and Wagner, Anjuli and Frey, Sarah and Dhanireddy, Shireesha and Taylor, Shaneil E and Hoover, Karen W and Stekler, Joanne D},
  title = {Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study},
  journal = {JMIR Research Protocols},
  year = {2026},
  doi = {10.2196/84625}
}
Kostenlos starten →